Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Adefovir is an active metabolite of the antiviral nucleoside analog adefovir dipivoxil (Item No. 28373).1 Adefovir is formed from adefovir dipivoxil by gastrointestinal carboxylesterase 2 (CES2).2 It inhibits cytopathogenicity induced by herpes simplex virus 1 (HSV-1) and HSV-2 (EC50 = 7 µg/ml for both in E6SM cells), HIV-1 and HIV-2 (EC50s = 1.8 and 2.5 µg/ml, respectively, in CEM cells), and varicella zoster virus (VZV; EC50 = 10 µg/ml in human embryonic lung fibroblasts).3 Adefovir (50 mg/kg, p.o.) reduces increases in lymph node viral DNA and serum IgG levels in a mouse model of AIDS induced by infection with the retroviral complex LP-BM5.4 It also inhibits tumor growth induced by Moloney sarcoma virus (MSV) infection in mice at the same dose.5
WARNING This product is not for human or veterinary use.
1. Orally bioavailable acyclic nucleoside phosphonate prodrugs: Adefovir dipivoxil and bis(POC)PMPA. Advances in Antiviral Drug Design 3, 69-91 (1999).
2. The role of human carboxylesterases in drug metabolism: Have we overlooked their importance? Pharmacotherapy 33(2), 210-222 (2013).
3. 6-
4. Pharmacokinetic and antiretroviral activity in mice of oral [P1,P2-
5. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-